Get started
Author

Gessica Marchesini

ORCID: 0000-0001-5501-9620
Observed ORCID: 0000-0001-5501-9620
OpenAlex ID: A5084620139
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study
2020 · Gessica Marchesini, Gianpaolo Nadali, et al. · British Journal of Haematology · 18
PDF
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients
2021 · Claudio Costantini, Emilia Nunzi, et al. · Infection and Immunity · 16
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants
2022 · Claudio Costantini, Emilia Nunzi, et al. · Infection and Immunity · 11
Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study
2020 · Gessica Marchesini, Gianpaolo Nadali, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017
2018 · Gianpaolo Nadali, Gessica Marchesini, et al. · Blood · 5
Invasive Mold Infections in Patients with Chronic Lymphoproliferative Disorders
2018 · Davide Facchinelli, Gessica Marchesini, et al. · Current Fungal Infection Reports · 1
Descriptive analysis of the Nationwide START2 antiphospholipid registry: Clinical and laboratory characteristics of patients with persistently positive antiphospholipid antibodies
2026 · Vittorio Pengo, Daniela Poli, et al. · Thrombosis Research
Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registry
2026 · Francesco Del Sole, Tommaso Bucci, et al. · Internal and Emergency Medicine
The Microbial Landscape of Hematological Patients at Risk for Aspergillosis
2018 · Luigina Romani, Claudio Costantini, et al.
Works count: 9
Citation count: 57
H-index: 5
I10-index: 3
Year
Topic
Type